Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Glycoengineering of Interferon-β 1a Improves Its Biophysical and Pharmacokinetic Properties.
Complementary and Alternative Medicine Use and Nutrient Intake Among Individuals with Multiple Sclerosis in the United States.
Progressive multifocal leukoencephalopathy after natalizumab discontinuation.
Changes in Fatigue and Cognition in Patients with Relapsing Forms of Multiple Sclerosis Treated with Natalizumab: The ENER-G Study.
RORγt-specific transcriptional interactomic inhibition suppresses autoimmunity associated with TH17 cells.
Prevalence of dysphagia in multiple sclerosis: a systematic review and meta-analysis.
Epstein-Barr Virus Specific Antibody Response in Multiple Sclerosis Patients during 21 Months of Natalizumab Treatment.
Short and long term variation in ultraviolet radiation and multiple sclerosis.
Peripheral neuropathy associated with mitochondrial disease in children.
Multiple sclerosis and sexual dysfunction.
HLA-DRB1-DQB1 Haplotypes Confer Susceptibility and Resistance to Multiple Sclerosis in Sardinia.
[Functional MRI during the execution of a motor task in patients with multiple sclerosis and fatigue.]
The impact of multiple sclerosis on family members: a review of the literature.
Fingolimod to treat severe multiple sclerosis after natalizumab-associated progressive multifocal leukoencephalopathy: a valid option?
Efficacy of glatiramer acetate in neuromyelitis optica spectrum disorder: a multicenter retrospective study.
Vitamin D, HLA-DRB1 and Epstein-Barr virus antibody levels in a prospective cohort of multiple sclerosis patients.
The immune balance between memory and regulatory B cells in NMO and the changes of the balance after methylprednisolone or rituximab therapy.
Protective effect of tanreqing injection on axon myelin damage in the brain of mouse model for experimental autoimmune encephalomyelitis.
Very early MS -- insights from MRI.
Cumulative review of thrombotic microangiopathy, thrombotic thrombocytopenic purpura and hemolytic uremic syndrome reports with SC interferon beta-1a.
The co-occurrence of multiple sclerosis and type 1 diabetes: Shared aetiologic features and clinical implication for MS aetiology.
Multiple sclerosis shrinks intralesional, and enlarges extralesional, brain parenchymal veins.
T cell vaccination benefits relapsing progressive multiple sclerosis patients: a randomized, double-blind clinical trial.
PTPN22 Alters the Development of Regulatory T Cells in the Thymus.
Distribution of JC polyomavirus genotypes in Tunisian renal transplant recipients between January 2008 and January 2011.

Pages